Forbes.com Selects Atherotech's VAP Cholesterol Test as One of 'Ten Ways to Live Longer'

Business Wire, March 14, 2005

What:   Stop smoking, get a pet, and get a VAP(TM) Cholesterol Test.
        According to Forbes.com, the VAP (Vertical Auto Profile)
        Cholesterol Test is one of "Ten Ways to Live Longer." The VAP
        Test was included for its ability to identify more people at
        risk for heart disease than routine cholesterol tests.

Why:    Cardiovascular diseases such as heart disease are the No. 1
        cause of death in the United States. This fact has challenged
        the medical community for decades, despite greater awareness
        about heart disease risks and significant advances in
        treatment. In fact, everyone knows of someone who has suffered
        a heart attack without warning. This devastating event often
        is followed by questions, including: Why weren't there any
        signs of illness? How did the traditional diagnostic tools
        miss such advanced heart disease? And how can we prevent this
        from happening in our own lives? The truth is that one of the
        key tools used to detect heart disease risk -- the routine
        cholesterol test -- identifies only about half of the patients
        who require treatment. In contrast, the advanced VAP Test
        identifies up to 90 percent of people at risk, allowing more
        patients to benefit from treatment options to prevent heart
        disease.

How:    Routine cholesterol tests are based on a calculated
        low-density lipoprotein (LDL, the "bad" cholesterol), which
        often is inaccurate. The VAP Test, however, provides direct
        measurements of LDL, and also measures a number of cholesterol
        subclasses that play important roles in the development of
        heart disease. These important measurements include LDL
        cholesterol density and hereditary factors such as Lp(a), also
        known as the "widow maker." The VAP Test is simple to perform
        and is available nationwide through national and regional
        diagnostic laboratories. It is reimbursed by most payors,
        including Medicare.

Who:    Atherotech, a pioneer in cardiodiagnostic technology, is
        dedicated to improving the early diagnosis and treatment of
        heart disease and other cardiovascular diseases that kill
        nearly 1 million Americans each year. Atherotech's VAP Test,
        the new standard of care in cholesterol risk assessment, also
        was named one of "five tests worth paying for" by The Wall
        Street Journal.

Where:  The Forbes.com article is located at
        www.forbes.com/health/2005/03/02/cx_vg_0302feat.html.
        Consumers interested in the VAP Cholesterol Test should speak
        with their doctors or visit www.thevaptest.com. Direct access
        to the VAP Test also is available at www.getavap.com.